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Abstract 
Background: Frail patients in any age group are more likely to die than those that are not 
frail. We aimed to evaluate the impact of frailty on clinical mortality, readmission rate and 
length of stay for emergency surgical patients of all ages. 
Methods: A multi-centre prospective cohort study was conducted on adult admissions to 
acute surgical units. Every patient presenting as a surgical emergency to secondary care, 
regardless of whether they ultimately underwent a surgical procedure was included. The 
study was carried out  during 2015 and 2016. 
Frailty was defined using the 7 point Clinical Frailty Scale. The primary outcome was 
mortality at Day 90. Secondary outcomes included: Mortality at day 30, length of stay and 
readmission within a day 30 period.. 
Results: The cohort included 2,279 patients (median age 54 years [IQR 36-72]; 56% 
female). Frailty was documented in patients of all ages: 1% in the under 40’s to 45% of 
those aged 80+. We found that each incremental step of worsening frailty was associated 
with an 80% increase in mortality at Day 90 (OR 1.80, 95% CI: 1.61-2.01) supporting a 
linear dose-response relationship. In addition, the most frail patients were increasingly 
likely to stay in hospital longer, be readmitted within 30 days, and die within 30 days. 
Conclusions: Worsening frailty at any age is associated with significantly poorer patient 
outcomes, including mortality in unselected acute surgical admissions. Assessment of 
frailty should be integrated into emergency surgical practice to allow prognostication and 
implementation of strategies to improve outcomes.   
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Introduction 
The concept of frailty is well established. Many clinicians diagnose it and know that it may 
negatively impact on a patient’s clinical condition. However, it is often diagnosed in a 
subjective “end of the bed” test rather than by using specific diagnostic criteria, despite 
being recognised as a factor influencing outcomes in geriatric research for many years (1–
4). Frailty is a state in which a vulnerable individual, has a diminished physiological 
capacity to respond to external stress such as infection or trauma (5). The deleterious 
effects include death, falls, disability, prolonged hospital stays and institutionalisation (2,5–
7). (7–14).  
There are many instruments used to measure frailty, with variation in their composition 
(15). Some use scoring systems based on multiple domains (16–18), whilst others use a 
single functional measurement as a proxy for frailty, such as grip strength or the timed up 
and go test (19,20). The Clinical Frailty Scale (CFS) (18), is a quick, simple and validated 
tool. Previous work in emergency general surgery (8) has shown that when used as a 
binary measure (frail or not frail) this scale predicts mortality an, length of stay. This seven 
point scale ranges from 1 (very fit) to 7 (severely frail) and uses clinical descriptors, with 
all information needed available from brief observation or review of the clinical notes. In a 
community setting a frailty assessment may be used as a preventative tool to monitor 
general health, or in a surgical setting to help explain to patients, their families and carers 
potential additional risks of clinical management procedures (21). Development of these 
tools, and frailty research generally, have historically focused on older populations, but the 
recent publication finding the existence of frailty and its’ negative impact on outcomes in 
younger adults (aged over 40 years) admitted as a surgical emergency (22) suggests that 
frailty is not a diagnosis exclusive to older adults. The exact prevalence of frailty is currently 
unknown, recent studies have reported this between 8% and as high as 37%, but any 
estimate is a combination of heterogeneous subgroups and shows variation depending on 
the tool used to detect frailty (23). In older, predominantly elective surgical populations 
frailty is associated with adverse outcomes (8,13,14). In all specialities, not just surgery, 
these associations have been assessed using frailty as predominantly a binary exposure 
variable (frail or not) or occasionally tertiary exposure variable (not frail, pre-frail and frail). 
While useful they are of limited value in relating the full range of frailty seen in clinical 
practice to outcome. 
This study aimed to evaluate the prevalence of frailty its associated risk of mortality, 
readmission rate and length of hospital stay in all adults, regardless of age, admitted as a 
surgical emergency. To evaluate the impact of frailty across the full range of the frailty 
spectrum the 7 point Clinical Frailty Scale was used and the outcome measures assessed 
for each incremental point increase.  
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Methods 
Prospective patient data were collated from six U.K. acute surgical units during two 
timeframes: May to July 2015 and June to August 2016.  Data collection was performed in 
accordance with the STROBE Statement and associated checklist (24). Inclusion criteria: 
patients aged over 18 years old admitted with a general surgical complaint, including those 
undergoing surgery and those managed conservatively. Patients were excluded if they had 
a urological, gynaecological or vascular diagnosis.  
Individual patient consent was not required as the study was deemed a service evaluation. 
As such it registered and approved with each institutional audit department, according to 
local guidelines. Anonymised data from each site was collected using a secure and 
anonymous data collection tool, stored in accordance with local guidelines, using standard 
commercially available spreadsheet software. 
Baseline demographic data were recorded In order to adjust for potential comorbidity, 
additional markers of poor health and adverse outcome following surgical intervention 
were also recorded; these were the number of regular medications (<=5, >5); haemoglobin 
(≤12.9g/L, >12.9g/L) and albumin (≤35g/L, >35g/L).  
Whether a patient underwent surgery was also recorded. Within 24 hours of admission 
and prior to any surgery, participants were assessed for frailty, recorded using CFS 
(Supplementary Figure 1). Each local team screened all new surgical admissions with the 
data gathered from patient electronic records, or case notes. Outcome data were collected 
from the hospital electronic clinical records. Data recorders were trained in the use of the 
CFS, by the local site lead, through face to face teaching sessions. Clinical outcomes of 
mortality (at 30 and 90-days), re-admission rates (at 30-days) and length of hospital stay 
were recorded.  
Public and Patient Involvement 
This work was conducted by the Older Persons Surgical Outcomes Collaborative 
(opsoc.eu). Public and patient involvement is integral to all of the projects developed. Our 
team compromises of patient representation, provided by Involving People Wales.  
Statistical analysis 
The study analysis was carried out using an a priori statistical analysis plan (available on 
request). Descriptive continuous data was reported with a mean and standard deviation 
(or with a median and interquartile range [IQR] for data exhibiting skew); and dichotomous 
data with a percentage and numerator and denominator. 
The primary outcome was mortality at Day 90, with secondary outcomes of: mortality at 
day 30;  length of stay and readmission within 30 days of discharge from hospital. Baseline 
demographic and clinical data were summarised for each surgical unit. 
Dichotomous outcomes were analysed using a multi-level logistic regression. Surgical 
units were fitted as hierarchical levels, to account for the clustered data. Length of stay 
was analysed with a negative binomial distribution to allow for modelling a varying variance 
structure. Our primary analysis evaluated the crude effect of frailty on clinical outcomes, 
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fitting frailty as a categorical predictor. The secondary analyses fitted the effect of frailty 
after adjustment for: age group (<65, 65-79, ≥80); sex; and albumin. Odds ratios (ORs) 
and 95% confidence intervals (95% CI) were reported. In an additional analysis, the effect 
of frailty was fitted as a continuous predictor of Day 90 mortality. All statistical analysis was 
performed using Stata 13.0.   
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Results 
There were 2,279 patients included in the study [median age 54 years (IQR 36-72); 56% 
female (1276/2279)]. No patients were excluded. Recruitment varied in number per 
surgical site, but demographic and baseline clinical status of patients were similar across 
sites as were outcomes (Supplementary Tables 1 and 2 respectively). On admission, 
12.7% (289/2279) of the cohort were frail (CFS >=5). Frailty was present across the entire 
age range; 1% (8/646) under 40’s; 5% (32/668) 40-59 years; 9% (30/331) 60-69 years; 
25% (82/328) 70-79 years and 45% (137/306) ≥80 years old (Supplementary Table 3). For 
follow-up data, seven patients (0.3%) had missing data. The analyses were based on a 
complete case analysis. A total of 128 patients were dead at Day 90 (6%) (Table 1). For 
secondary outcomes, the median length of hospital stay was 4 days (IQR 2-7); 404 patients 
were re-admitted (19%) and 79 (4%) had died at 30 days post-admission (Supplemental 
Table 2). Within the frail group (CFS >=5), 19% (54/286) experienced mortality at 90-days 
compared to 3.6% (72/1985) of non-frail (Supplementary Table 4). Similar results were 
found from 30-day mortality. Re-admission occurred in 23% (64/284) of frail patients 
versus 17% (340/1974) of non-frail patients. The length of stay was 3 (IQR 2-5) days in 
those who were not frail compared to 5 (IQR 3-11), 7.5 (IQR 4-18) and 5 (IQR 3-7) days 
for patients who were mildly frail (CFS=5), moderately frail (and CFS=6) severely frail 
(CSF=7).Primary outcome: The odds of mortality at Day 90 was higher for those patients 
with an increased level of frailty. Patients with a CFS of very well (CFS=2) had a crude 
odds ratio (OR) of 2.25 (95% CI 1.08-4.68) compared to patients with a CFS of very fit 
(CFS=1). The OR of mortality increased to 8.54 (95% CI 4.12-17.73), 19.5 (95% CI 9.16-
41.88) and 58.2 (95% CI 22.6-149.9) for patients with a CFS of: mildly frail (CFS=5); 
moderately frail (CFS=6); and severely frail (CFS=7) respectively (Table 2). An incremental 
single unit increase in frailty was found to increase odds of Day 90 mortality by 80% (95% 
CI 1.61-2.01; Figure 1). Secondary outcomes: Increased frailty was linked to increased 
mortality at Day 30 (Supplementary Table 5).   The mean length of stay was found as 4.6 
days for patients with a CFS of very fit (CFS=1). The increase mean length of stay 
increased for patients with worsening frailty. The mean length of stay increased by 2.60 
(95CI% 2.25-3.02), 2.89 (95% CI 2.37-3.53), 2.30 (95% CI 1.64-3.30) times for patients 
with CFS of mildly to severely frail (CFS=5-7) (Supplementary Table 6). Increased frailty 
was associated with an increased re-admission rate, the ORs were 1.96 (95% CI 1.28-
2.98), 2.56 (95% CI 1.49-4.37), and 0.90 (0.26-3.06) for a CFS of mildly to severely frail 
(Supplementary Table 7). 
Secondary analyses, after adjustment by age group, sex and albumin the effect of frailty 
was lower, but remained clinically important (Table 2, Supplementary Tables 5-7). The 
adjusted odds ratio (aOR) of mortality at Day 90 was 2.62 (95% CI 1.14-6.03), 5.39 (95% 
CI 2.28-12.76), and 24.6 (95% CI 8.42-71.88) for frailty score 5 to 7. Similar results were 
reported from the other secondary outcomes (Supplementary Tables 5-7).  
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Discussion 
This is the first study to assess frailty in adults of all ages admitted as a surgical emergency, 
finding that frailty exists in all age groups and is not exclusive to the older adult population. 
In addition, the presence of frailty predicts mortality in these patients regardless of age and 
for each incremental point of frailty, the OR for 90 day mortality increased by 80%. After 
adjusting for key confounding effects, including patient age, gender and comorbidity, frailty 
was still associated with poorer clinical outcomes. Given the fact that our study was 
conducted in the real world setting using data from consecutive surgical admissions, our 
findings highlight the need for routine integration of frailty scores in clinical practice and 
interventions to modify frailty and improve outcomes.  
In other studies, mortality rates for frail people have varied widely (OR ranging from 1.1 to 
31.84), with results being difficult to compare due to the heterogeneity in study designs, 
and the type of frailty assessment used (8,14,25–28). In acute general surgery, two studies 
have previously reported an association between frailty and 90 day mortality (8,14), 
however, these studies focussed on older patients only. Other studies have linked length 
of stay to frailty however these are predominantly from elective surgical populations who 
are likely to have been pre-operatively assessed as fit enough to undergo planned surgery 
(10,12,13,29–31). For example Robinson et al found that in both elective colorectal, and a 
mixed cohort of cardiothoracic and colorectal patients increasing frailty was associated 
with readmission to hospital and an increased length of hospital stay (13,32). 
This study demonstrated that for each incremental shift to a higher level of frailty there was 
an associated worsening of outcomes, a concept that is readily understood and 
explainable to patients and carers. Previously frailty has been evaluated in terms of frail or 
not, and occasionally with an intermediate category of pre-frail in between. By 
demonstrating that frailty is associated with worsening outcome across an incremental 
range of the condition and changes for each step-wise increase the opportunities for frailty 
research and potential interventions are substantially broadened. These results clearly 
demonstrate the potential impact and likely benefit on clinical outcomes through population 
level frailty prevention strategies or interventions. Furthermore, the CFS has the benefit of 
being an extremely simple, quick and easy to perform frailty measure. 
Strengths and Limitations of the study 
There are several strengths to this study: consecutive emergency patients recruited under 
general surgeons in multiple UK acute hospitals resulted in inclusion of differing 
populations and minimising of any influence of local population or admission practices; 
patient characteristics and outcome data demonstrated that the patients were similar 
across all of the sites and finally, less than 0.5% of outcome data were missing. 
However, the authors acknowledge limitations, primarily that the population assessed was 
based in the UK which could limit generalisability beyond similar Western populations and 
settings. Most notably the surgical population used in this study considered any patient 
admitted under a surgical team, regardless of whether they undergo surgery or not. While 
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that may limit some of the precision from a purely surgical perspective, for non surgical 
and community referral patients for an acute surgical opinion the CFS represents the whole 
surgical population. Thus allowing community teams to educate and inform patients and 
their relatives before a surgical opinion is even received, thus potentially influencing 
referral decisions, especially in those with the very highest frailty scores. Another potential 
limitation is that although the data collectors were trained to use the CFS tool, no validation 
took place meaning that intra-rater bias cannot be excluded. However, the prevalence of 
individual frailty scores were consistent across sites, which does potentially mitigate 
against this. 
The implications for future clinical practice:  
The management of the frail, emergency surgical patient is challenging, regardless of age. 
Patients are living longer and are becoming increasingly co-morbid (33). The idea that 
frailty contributes to an increased risk of mortality is not new in older patients but these 
data show that this can now be applied to all surgical admissions irrespective of age.  
Surgeons are faced with challenging decision-making processes and it is not standard 
practice to ‘turn down’ a frail patient for emergency surgery based on their clinical 
condition. In the UK, recent recommendations from the National Emergency Laparotomy 
Audit NELA framework are that higher risk surgical patients are managed in intensive care 
(34). Unfortunately, however, resources for intensive care post operatively are costly, not 
limitless and not appropriate for all patients. This has led to an increased focus on futility 
of surgical intervention and what the likelihood is of returning the patient to reasonable 
quality of life. This simple frailty assessment should be included in that rigorous 
assessment process alongside American Society of Anaesthesiologists (ASA) grade and 
P-Possum score. 
Public health awareness and education is required to manage frail patients in the 
community, and the CFS could be used to identify those at risk by clinicals in primary care. 
By the time a frail patient presents as a surgical emergency, it is too late to alter the 
potential risk of death. Whilst Interventions to try to improve frailty can be started in the 
community if those at risk are identified and offered the opportunity to reduce their risk. 
Part of any frailty intervention should include clear information on the risk of death 
associated with the frail state and the decision making process that may occur if they were 
to develop an acute surgical problem. The CFS could easily be used by emergency 
physicians before assessment by surgical teams has begun to begin to inform health care 
choices in relation to surgical intervention.  
Much work has been done to improve outcomes in all patients undergoing elective major 
surgery, regardless of age. For example, the enhanced recovery programme after surgery 
(ERAS) consists of a multi-modal approach that includes: pre-operative counselling; 
shorter-fasting times; early mobility and avoidance of drains. This pathway is now standard 
peri-operative practice across the UK, leading to optimisation of patient outcomes (35,36). 
However, these programs are typically focused on older age groups, in future a more 
targeted approach to improve post-operative outcomes may be facilitated by using the 
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CFS. In high resource settings, use of electronic frailty index has been shown to be 
associated with mortality in older adults (37) and thus such electronic based tools may also 
provide useful information in surgical patients, but the prognostic value in surgical setting 
in all ages needs to be tested perhaps using the same approach.  
Conclusions 
This study has shown that frailty can exist in all ages of the adult emergency general 
surgical population. There is an approximately linear relationship between increasing CFS 
at admission and increased odds of Day 90 mortality. The CFS should be integrated into 
primary care for education and management. Frailty can be used emergency surgical 
practice to allow prognostication and implementation of strategies to improve outcomes in 
this vulnerable population.   
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1 Very fit 
Robust, active, energetic, well-motivated and fit; these people commonly 
exercise regularly and are in the most fit group for their age 
2 Well  
Without active disease but less well than those in category 1 
3 Well, with treated comorbid disease 
Disease symptoms are well controlled compared with those in category 4 
4 Apparently vulnerable 
Although not frankly dependent, these people commonly complain of being 
“slowed up” or have disease symptoms 
5 Mildly frail 
With limited dependence on others for instrumental activities of daily living 
6 Moderately frail 
Help is needed with both instrumental and non-instrumental activities of daily 
living 
7 Severely frail 
Completely dependent on others for activities of daily living, or terminally ill 
Supplementary Figure 1 – The Canadian Study of Health and Ageing (CSHA) Clinical 
Frailty Scale (18) 
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Table 1 – Demographic characteristics of the study participants, by Mortality at Day 90.  
    Mortality at Day 90 
    Yes No       Total 
        (n=126)     (n=2145)    (n=2271) 
Patient Age  
(years) 
 
Under 65 34 27% 1,419 66% 1,453 64% 
65 - 79 39 31% 475 22% 514 23% 
Over 80 53 42% 251 12% 304 13% 
Gender Female 56 44% 1,219 57% 1,275 56% 
  Male 70 56% 926 43% 996 44% 
Albumin Normal 24 19% 1,263 59% 1,287 57% 
  Low 101 80% 811 38% 912 40% 
  missing 1 1% 71 3% 72 3% 
Haemoglobin Normal 47 37% 1,342 63% 1,389 61% 
  Low 78 62% 778 36% 856 38% 
  missing 1 1%   0%   0% 
  Normal 76 60% 1,874 87% 1,950 86% 
eGFR <60 32 25% 219 10% 251 11% 
  <30 18 14% 52 2% 70 3% 
CRP Normal 2 2% 181 8% 183 8% 
  >3 124 98% 1,964 92% 2,088 92% 
Poly No  36 29% 1,342 63% 1,378 61% 
pharmacy Yes 84 67% 785 37% 869 38% 
  missing 6 5% 18 1% 24 1% 
Multimorbidity No 49 39% 1,261 59% 1,310 58% 
  Yes 67 53% 665 31% 732 32% 
  missing 10 8% 219 10% 229 10% 
Clinical Frailty 
Scale  
1 – Very Fit 12 10% 753 35% 765 34% 
2 – Very Well 19 15% 528 25% 547 24% 
3 – Well, with comorbid disease 21 17% 394 18% 415 18% 
4 – Apparently vulnerable  20 16% 238 11% 258 11% 
5 – Mildly Frail 21 17% 154 7% 175 8% 
6 – Moderately Frail 20 16% 64 3% 84 4% 
7 – Severely Frail 13 10% 14 1% 27 1% 
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Table 2 – Odds of Day 90 mortality in those with an increased frailty index, compared with those that are 
defined as very fit (Primary outcome) 
    Unadjusted     
Variable Level OR (95% CI) p-value   OR (95% CI) p-value 
Clinical Frailty 
Scale& 
1     -   Reference   -        -   Reference   -   
2 2.25, (1.08, 4.68) 0.029   1.68, (0.79, 3.58) 0.175 
3 3.34, (1.62, 6.86) 0.001   1.63, (0.75, 3.55) 0.211 
4 5.26, (2.53, 10.93) <0.001   2.09, (0.93, 4.66) 0.071 
5 8.54, (4.12, 17.73) <0.001   2.62, (1.14, 6.03) 0.022 
6 19.5, (9.16, 41.88) <0.001   5.39, (2.28, 12.76) <0.001 
7 58.2, (22.6, 149.9) <0.001   24.6, (8.42, 71.88) <0.001 
              
Age group 
Under 65 -   Reference   -     -   Reference   -   
65 to 80 2.26, (1.34, 3.81) 0.002   1.72, (1.01, 2.94) 0.043 
Over 80 3.88, (2.23, 6.75) <0.001   3.28, (1.89, 5.71) <0.001 
              
Sex Female 1.68, (1.15, 2.26) 0.007   1.66, (1.12, 2.47) 0.01 
              
Albumin Abnormal 4.85, (3.02, 7.80) <0.001   4.55, (2.82, 7.36) <0.001 
Key:&  1=Very Fit;  
2=Very Well;  
3= Well, with comorbid disease;  
4=Apparently vulnerable;  
5= Mildly frail;  
6=Moderately Frail;  
7=Severely Frail 
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Figure 1 – Crude Odds ratio of mortality at Day 90, for individuals with an increased risk of frailty, using 
the compared to very fit participants, using the Clinical Frailty Scale (CFS).  
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